Prediabetes. You hear the term often, but what does it really mean to patients, pharmacists, and other retail clinicians?
Diabetes affects 25.8 million people or 8.3% of the American population, with an additional 79 million patients classified as having prediabetes. Of those 25.8 million people, approximately 90% to 95% have type 2 diabetes. In 2012, the total cost-burden of diabetes, including both direct medical costs and reduced productivity, was $245 billion.
Our fast-paced, task-oriented society demands more and more from us each and every day, eating up the free time we strive to obtain and creating obstacles that we attempt to conquer. Having too many tasks to accomplish, too little free time to do them, a decreased quality of life as a result, and the barriers caused by chronic diseases place exercise on the back burner for most people.
Diabetes is a disease state that is both psychologically and economically draining on the patient and on the economy as a whole. According to the American Diabetes Association (ADA), there are 25.8 million people in the United States living with diabetes, with an even greater prevalence in minority populations.
Two landmark studies, the Diabetes Control and Complications Trial and the United Kingdom Prospective Diabetes Study, have shown the importance of glycemic control in patients with type 1 or type 2 diabetes to help minimize macrovascular and microvascular complications.
It can take as little as 1 minute to make a difference in the life and future of your pharmacy customers. Learn more about a simple tool to get you started.
There is confusion within the general population about which is the healthiest and most effective dietary regimen. Many “fad” diets—such as low-fat or high-protein—are promoted to cause abnormally large weight reductions, but the reality is that weight frequently returns without the proper amount of exercise.
Diabetes is an important disease state causing significant morbidity and mortality throughout the United States and worldwide. The current obesity epidemic, together with the US aging population, is fueling the rapid increase in diabetes prevalence.
We are living in an era where the prevalence of diabetes continues to be on the rise. This disease affects nearly 25.8 million, or 1 in 12, Americans.

Results 1 - 9 of 9
  • American Health & Drug Benefits
  • The Journal of Hematology Oncology Pharmacy
  • Lynx CME
  • The Oncology Pharmacist